Get the tools used by (smart)2 investors.

NAV / Share Forecast Count of Estimates for Insulet Corporation

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PODD: Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...

258.75 USD
Price
USD
Fair Value
Upside
160.19 - 289.46
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Insulet Corporation's NAV / Share Forecast Count of Estimates:

Dec 2026Dec 2028Dec 2030Dec 2032Dec 20340011

Performance Summary
  • Insulet's nav / share forecast count of estimates for the next fiscal year is 1
  • Insulet's nav / share forecast count of estimates is expected to average 1 over the next 5 fiscal years.
  • Insulet's is expected to deliver median nav / share forecast count of estimates of 1 over the next 5 fiscal years.

How does Insulet's NAV / Share Forecast Count of Estimates benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Insulet Corporation because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: NAV / Share Forecast Count of Estimates

Hide this widget
nav_share_proj_count
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to NAV / Share Forecast Count of Estimates in the forecast category include:

  • Consensus FFO / Share, Actual - Reported FFO per share including any adjustments for unusual items proposed by management. This metric is useful for analyst forecast vs actual analysis since deciding which add backs are truly "unusual" is subjective.
  • EBITDA Forecast Revision Date - The date/time at which the current consensus estimate of forecasted EBITDA was last updated.
  • FFO Forecast Revision Date - The date/time at which the current consensus estimate of forecasted FFO was last updated.
  • Marginal Tax Rate - Marginal tax rate used for financial modeling.
View Full List

Search for metric or datapoint

NAV / Share Forecast Count of Estimates

Standard deviation in forecasted NAV / share.

Definition of NAV / Share Forecast Count of Estimates

Hide this widget
Standard deviation in forecasted NAV / share.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
122350150250

The chart above depicts the distribution of nav / share forecast count of estimates for companies operating in the Healthcare sector in the Developed economic region. Over 300 companies were considered in this analysis, and 305 had meaningful values. The average nav / share forecast count of estimates of companies in the sector is 1 with a standard deviation of 0.

Insulet Corporation's NAV / Share Forecast Count of Estimates of 1 ranks in the 0.0% percentile for the sector. The following table provides additional summary stats:

NAV / Share Forecast Count of Estimates In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents309
Included Constituents305
Min1
Max3
Median1
Mean1
Standard Deviation0

You can find companies with similar nav / share forecast count of estimates using this stock screener.

All rights reserved. Terms Of Use